Santori & Peters Inc’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $676K | Hold |
1,868
| – | – | 0.19% | 42 |
|
|
2026
Q1 | $657K | Hold |
1,868
| – | – | 0.2% | 37 |
|
|
2025
Q4 | $611K | Hold |
1,868
| – | – | 0.21% | 37 |
|
|
2025
Q3 | $527K | Hold |
1,868
| – | – | 0.19% | 39 |
|
|
2025
Q2 | $522K | Hold |
1,868
| – | – | 0.19% | 41 |
|
|
2025
Q1 | $582K | Sell |
1,868
-81
| -4% | -$23.9K | 0.23% | 35 |
|
|
2024
Q4 | $508K | Hold |
1,949
| – | – | 0.19% | 39 |
|
|
2024
Q3 | $628K | Hold |
1,949
| – | – | 0.25% | 35 |
|
|
2024
Q2 | $609K | Sell |
1,949
-12
| -0.6% | -$3.52K | 0.26% | 30 |
|
|
2024
Q1 | $557K | Buy |
1,961
+15
| +0.8% | +$4.39K | 0.24% | 29 |
|
|
2023
Q4 | $561K | Buy |
1,946
+14
| +0.7% | +$3.81K | 0.27% | 29 |
|
|
2023
Q3 | $519K | Buy |
1,932
+14
| +0.7% | +$3.49K | 0.28% | 30 |
|
|
2023
Q2 | $426K | Buy |
1,918
+17
| +0.9% | +$3.94K | 0.21% | 33 |
|
|
2023
Q1 | $460K | Buy |
1,901
+16
| +0.8% | +$3.93K | 0.25% | 31 |
|
|
2022
Q4 | $495K | Buy |
1,885
+12
| +0.6% | +$3.22K | 0.29% | 26 |
|
|
2022
Q3 | $422K | Buy |
1,873
+14
| +0.8% | +$3.39K | 0.28% | 30 |
|
|
2022
Q2 | $452K | Buy |
1,859
+13
| +0.7% | +$3.19K | 0.29% | 31 |
|
|
2022
Q1 | $446K | Buy |
1,846
+14
| +0.8% | +$3.22K | 0.25% | 35 |
|
|
2021
Q4 | $412K | Buy |
1,832
+14
| +0.8% | +$2.96K | 0.22% | 37 |
|
|
2021
Q3 | $386K | Buy |
1,818
+13
| +0.7% | +$2.99K | 0.22% | 37 |
|
|
2021
Q2 | $440K | Buy |
1,805
+12
| +0.7% | +$2.95K | 0.25% | 36 |
|
|
2021
Q1 | $446K | Buy |
1,793
+12
| +0.7% | +$2.86K | 0.27% | 38 |
|
|
2020
Q4 | $424K | Sell |
1,781
-20
| -1% | -$4.61K | 0.24% | 50 |
|
|
2020
Q3 | $457K | Buy |
1,801
+50
| +3% | +$12.4K | 0.3% | 42 |
|
|
2020
Q2 | $413K | Buy |
1,751
+11
| +0.6% | +$2.51K | 0.32% | 36 |
|
|
2020
Q1 | $352K | Buy |
1,740
+13
| +0.8% | +$2.84K | 0.3% | 48 |
|
|
2019
Q4 | $416K | Buy |
1,727
+10
| +0.6% | +$2.2K | 0.27% | 47 |
|
|
2019
Q3 | $332K | Buy |
1,717
+11
| +0.6% | +$2.11K | 0.24% | 50 |
|
|
2019
Q2 | $314K | Buy |
1,706
+13
| +0.8% | +$2.33K | 0.23% | 52 |
|
|
2019
Q1 | $321K | Buy |
1,693
+12
| +0.7% | +$2.29K | 0.27% | 36 |
|
|
2018
Q4 | $327K | Buy |
1,681
+10
| +0.6% | +$1.95K | 0.29% | 46 |
|
|
2018
Q3 | $346K | Hold |
1,671
| – | – | 0.27% | 36 |
|
|
2018
Q2 | $308K | Hold |
1,671
| – | – | 0.27% | 35 |
|
|
2018
Q1 | $284K | Hold |
1,671
| – | – | 0.26% | 39 |
|
|
2017
Q4 | $289K | Buy |
+1,671
| New | +$296K | 0.26% | 40 |
|
Other funds holding AMGN
FFM
Santori & Peters Inc's AMGN Position: Q2 2026 in Review
Santori & Peters Inc held its Amgen (AMGN) position steady in Q2 2026 at 1,868 shares worth $676K. The position accounts for 0.19% of the portfolio, ranked #42.
Santori & Peters Inc first reported a position in AMGN in Q4 2017 and has held it in 35 quarters since. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Santori & Peters Inc held 1,868 shares of Amgen worth $676K as of Q2 2026.
- Santori & Peters Inc left its Amgen share count unchanged in Q2 2026.
- Amgen made up 0.19% of Santori & Peters Inc's portfolio in Q2 2026, its #42 holding.
- Santori & Peters Inc first reported a position in Amgen in Q4 2017 and has held it in 35 quarters since.
- 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Santori & Peters Inc's 13F filing for Q2 2026, filed 24 Jul 2026.